Eli Lilly weight loss drug approved in China
The Chinese drug regulator, the National Medical Products Administration (NMPA), has approved Eli Lilly’s (NYSE:LLY) weight ...
BioWorld4mon
China’s ‘growing enthusiasm’ for GLP-1s
After capturing the North American market with Wegovy (semaglutide) and Zepbound (tirzepatide), Novo Nordisk A/S and Eli ... Eyeing the success of GLP-1s are Chinese biopharmaceutical companies ...
thecardiologyadvisor.com28d
Tirzepatide Treatment Reduces Weight and Diabetes Risk Across 3 Years
Tirzepatide vs placebo was associated with reduced body weight and risk for progression to type 2 diabetes across 3 years. Tirzepatide significantly reduces body weight and prevents progression to ...
National Institute for Health and Care Excellence1mon
Tirzepatide for managing overweight and obesity
Tirzepatide is recommended as an option for managing overweight ... Use a lower BMI threshold (usually reduced by 2.5 kg/m 2) for people from South Asian, Chinese, other Asian, Middle Eastern, Black ...